Nutriband Inc. Common Stock

NTRBNASDAQ • USD
5.76 USD
↗ 0.00 (0.00%)AT CLOSE (03:59 PM EDT)
5.62
↘ 0.14 (2.52%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
5.62
↘ 0.14 (2.52%)
🔴Market: CLOSED

Nutriband Inc. Common Stock (NTRB) trades at $5.72 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Oct 23, 2026.

Open?$5.94
High?$5.94
Low?$5.71
Prev. Close?$5.76
Volume?6.8K
Avg. Volume?101.0K
VWAP?$5.79
Rel. Volume?0.07x
Bid / Ask
Bid?$5.00 × 100
Ask?$6.23 × 900
Spread?$1.23
Midpoint?$5.62
Valuation & Ratios
Market Cap?70.0M
Shares Out?12.2M
Float?2.2M
Float %?18.3%
P/E Ratio?N/A
P/B Ratio?13.14
EPS?-$0.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Employees
3
Market Cap
70.0M
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2017-06-20
Address
121 S. ORANGE AVE.
ORLANDO, FL 32801
Phone: 407 377-6695
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
83
Short Sent.?
66
Piotroski F-Score?3/9Weak
Altman Z-Score?29.82Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.91%Elevated
Short Interest?153.4K
Days to Cover?1.0
Free Float2.2M
Avg Daily Volume197.7K
Settlement Date2026-09-30
Financial Health
Current Ratio?4.21Strong
Quick Ratio?4.02Strong
Cash Ratio?3.77Strong
Debt/Equity?0.03Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
15
13.14HIGH▾
P/S?
Peers
100
S&P
3
43.28HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.7CHEAP▾
EV/Sales?
Peers
100
S&P
3
41.26HIGH▾
Returns & Efficiency
ROE?
S&P
3
-130.7%WEAK▾
ROA?
S&P
3
-110.6%WEAK▾
Cash Flow & Enterprise
FCF?$-3632420
Enterprise Value?$66.7M
Fundamentals ratios updated end of day